Trending Topic

2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

From advances in targeted therapies to the integration of AI and steps towards precision medicine, 2024 brought many exciting developments in the field. With 2025 now unfolding, many of these are likely to continue gaining momentum and potentially redefine patient care. In this latest edition of touchREVIEWS in RMD, we’re excited to present a collection […]

Tiago Torres, EADV Spring Symposium 2021: Comorbidities in Psoriasis

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 10th 2021

We were delighted to speak with our Expert Faculty member, Prof. Tiago Torres (Centro Hospitalar Universitário do Porto, Portugal), about the need to look for comorbidities in psoriasis.

His talk entitled ‘Is there a need to look for comorbidities in psoriasis?’ was presented at the EADV Spring Symposium, 6-7 May 2021.

Questions

  1. What cardiometabolic comorbidities are associated with psoriasis and why are these underdiagnosed and undertreated? (0:18)
  2. How do these comorbidities impact the treatment choices for our patients with psoriasis? (1:19)
  3. How can we improve the global management of patients with psoriasis and what are the benefits of such management? (1:58)
  4. What were the key take-home messages of the session? (2:49)

Disclosures: Tiago Torres has acted as a consultant, advisor, or speaker for Abbvie, Almirall, Amgen, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers-Squibb, Celgene, Janssen, LEO Pharma, Eli-Lilly, MSD, Mylan, Novartis, Pfizer, Sandoz, Samsung-Bioepis, UCB and Viatris.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Gina Furnival.

Filmed as a highlight of EADV Spring Symposium 2021 (Virtual).

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup